Abstract
We have previously demonstrated serotonin (5-HT) alterations in the hippocampi (HPC) and neocortices of patients with mesial temporal lobe epilepsy (MTLE) as compared with those presenting with neocortical temporal lobe epilepsy (NTLE). Now, we extend these findings by analysis of L-tryptophan (L-Trp) concentrations, recorded within the same patient population. We used an electrochemical technology, that is, neuromolecular imaging (NMI) with a novel miniature sensor, the carbon-based BRODERICK PROBEĀ®. These sensors detected L-Trp in resected HPC subparcellations as well as in temporal lobe neocortex of patients diagnosed with either MTLE or NTLE. Five patients were classified as NTLE and nine as MTLE based on magnetic resonance imaging (MRI) and intracranial EEG evaluations. HPC subparcellations studied in 12 of 14 patients were (1) granular cells of the dentate gyrus (DG); (2) polymorphic layer of the DG; and (3) HPC pyramidal layer. Layer IV of temporal neocortex was studied in all 14 patients. A specific oxidation potential voltametrically provided the signature for L-Trp. The results showed that in granular cells of DG and, in pyramidal layer, L-Trp concentrations were significantly higher in MTLE patients in contrast to NTLE patients (p < 0.05, Mann-Whitney rank sum). Taken together with our recently published data, L-Trp concentrations were inversely proportional to 5-HT concentrations in these neuroanatomic substrates. In polymorphic layer of the DG, there was a trend toward lower 5-HT and higher L-Trp concentrations in MTLE patients. In neocortical layer IV, NTLE patients had significantly lower L-Trp concentrations than MTLE patients; however, 5-HT concentrations were similar in both groups (p < 0.01, Mann-Whitney rank sum). Our results indicate markedly different alterations in L-Trp and 5-HT synthesis and metabolism in the epileptogenic temporal lobes of patients with MTLE as compared with NTLE. Considering that various L-Trp metabolites may have proconvulsant or anticonvulsant properties, these alterations have important implications in the pathogenesis of both types of epilepsy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bobula B, Zahorodna A, Bijak M. Different receptor subtypes are involved in the serotonin-induced modulation of epileptiform activity in rat frontal cortex in vitro. J Physiol Pharmacol 2001;52:265ā274.
Waterhouse BD. Electrophysiological assessment of monamine synaptic function in neuronal circuits of seizure susceptible brains. Life Sci 1986;39:807ā818.
Lerner Natoli M. Serotonin and kindling development. Int J Neurosci 1987;36:139ā151.
Jobe PC, Dailey JW, Reigel CE. Noradrenergic and serotonergic determinants of seizure susceptibility and severity in genetically epilepsy prone rats. Life Sci 1986;39:775ā782.
Laird HE, Dailey JW, Jobe PC. Neurotransmitter abnormalities in genetically epileptic rodents. Fed Proc 1984;43:2505ā2509.
Neuman BS. Suppression of penicillin-induced epileptiform activity by noxious stimulation: mediation by 5-hydroxytryptamine. Electroencephal Clin Neurophysiol 1986;64:546ā555.
Lu KT, Gean PW. Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine1A receptor activation. Neuroscience 1998;86:729ā737.
Andrade R, Nicoll RA. Pharmacologically distinct actions of serotonin on single pyramidal neurons of the rat hippocampus recorded in vitro. J Physiol 1987;394:99ā124.
Barlow-Walden LR, Reigter RJ, Abe M, et al. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 1995;26:497ā502.
Luow D, Sutherland GR, Glavin GB, Girvin J. A study of monamine metabolism in human epilepsy. Can J Neurol Sci 1989;16:394ā397.
Reiter RJ, Tan DX, Poeggeler B, Menendez PA. Melatonin as a free radical scavenger: implications for aging and age-related diseases. Ann NY Acad Sci 1994;719:1ā12.
Stone TW. Endogenous neurotoxins from tryptophan. Toxicon 2001; 39:61ā73.
Kabuto H, Yokoi I, Norio O. Melatonin inhibits iron-induced epileptic discharges in rats by suppressing peroxidation. Epilepsia 1998; 39:237ā243.
Munoz-Hoyos A, Sanchez-Forte M, Molina-Carballo A, et al. Melatoninās role as an anticonvulsant and neuronal protector: experimental and clinical evidence. J Child Neurol. 1998;13:501ā509.
Noguchi KK. NMDA antagonist-induced neurotoxicity and psychosis. In: Massaro EJ, Schardein JL, Broderick PA, Schlaepfer TE, Mattson JL, eds. Handbook of Neruotoxicology, Vol 2. (Totowa, NJ: Humana Press Inc.; 2001.
Hayashi T. A physiological study of epileptic seizures following cortical stimulation in animals and its application to human clinics. Jpn J Physiol 1952;3:46ā64.
Stone TW. Kynurenic acid antagonists and kynurenine pathway inhibitors. Expert Opin Invest. Drugs 2001; 10:633ā645.
Bibileishvili S. Amino acid tryptophan, as an antiepileptic agent. Klin Med (Mosk) 1980;58: 91ā106.
Afifi AK, Bergman RA. Brain Neuroscience. Baltimore: Urban and Schwarzenberg Inc.; 1980.
Mathern GW, Babb TL, Armstrong DL. Hippocampal sclerosis. In: Engel J Jr., Pedley TA, editors. Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven Pub.; 1997:1807ā1817.
Broderick PA, Pacia SV, Doyle WK, Devinsky O. Monoamine neurotransmitters in resected hippocampal subparcellations from neocortical and mesial temporal lobe epilepsy patients: in situ microvoltammetric studies., Brain Res 2000;878:48ā63.
Broderick PA. Microsensors detect neuroadaptation by cocaine: serotonin released in motor basal ganglia is not rhythmic with movement. In Massaro EJ, Broderick PA, Mattson JL, Schardein JL, Schlaepfer TE, editors. Handbook of Neurotoxicology, Vol. 2. Totowa, NJ: Humana Press; 2001, pp. 323ā367.
Broderick PA. Rat striatal dopamine release mechanisms of cocaine. NIDA Res. Mono. Ser. 1986;75: 367ā370.
Broderick PA, Gibson GE. Dopamine and serotonin in rat striatum during in vivo hypoxic-hypoxia. Metab Br Dis 1989;4: 143ā153.
Broderick PA. State-of-the-art microelectrodes for in vivo voltammetry. Electroanalysis 1990;2: 241ā251.
Broderick PA. Microelectrodes and their use in cathodic electrochemical current arrangement with telemetric application. European Patent 90914306.7, 1996.
Broderick PA. Microelectrodes and their use in an electrochemical arrangement with telemetric application. US Patent 5,938,903, 1999.
Broderick PA. In vivo electrochemical studies of gradient effects of (sc) cocaine on dopamine and serotonin release in dorsal striatum of conscious rats, Pharmacol Biochem Behav 1993;46:973ā984.
Broderick PA, Pacia SV. Identification, diagnosis, and treatment of neuropathologies, neurotoxicities, tumors, and brain and spinal cord injuries using microelectrodes with microvoltammetry. U.S. 10/118,571 and Foreign Patent pending # PCTUS021/11244, 2002.
Coury LA Jr, Huber EW, Heineman WR. Applications of modified electrodes in the voltammetric determination of catecholamine neurotransmitters. Biotechnology 1989;11: 1ā37.
Heyes MP, Saito K, Devinsky O, Nadi SN. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures. Epilepsia 1994;35:251ā257.
Stone TW. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog Neurobiol 2001;64:185ā218.
Van der Stelt HM, Olivier B, Westenburg HGM. Effects of availability of tryptophan on serotonin levels in the dorsal hippocampus of rats. Society for Neuroscience 32nd annual meeting, Orlando, FL, 2002.
Statnick MA, Dailey JW, Jobe PC, Browning RA. Abnormalities in brain serotonin concentration, high affinity uptake, and tryptophan hydroxylase activity in severe-seizure genetically epilepsy-prone rats. Epilepsia 1996; 37:311ā321.
Scharfman HE, Ofer A. Pretreatment with L-kynurenine, the precursor to the excitatory amino acid antagonist kynurenic acid, suppresses epileptiform activity in combined hippocampal/entorhinal slices. Neurosci Lett 1997; 224:115ā118.
Moroni F. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. Eur J Pharmacol. 1999;375:87ā100.
Gentsch K, Heinemann U, Schmitz B, Behr J. Fenfluramine blocks low Mg2+-induced epileptiform activity in rat entorhinal corx. Epilepsia 2001;35:251ā257.
Salgado-Commissariat D, Alkadhi KA. Serotonin inhibits epileptiform discharge by activation of 5-HTIA receptors in CA1 pyramidal neurons, Neuropharmacology 1997;36:1705ā1712.
Shouse MN, Staba RJ, Ko PY, Saquib SF, Farber PR. Monoamines and seizures: microdialysis findings in locus ceruleus and amygdala before and during amygdala kindling. Brain Res 2001;892:176ā192.
Fedi M, Reutens D, Okazawa H, Andermann F, Boling W, Dubeau F, et al. Localizing value of-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin. Neurology 2001;57:1629ā1636.
Natsume J, Kumakura Y, Bernasconi N, et al. Ī±-(11C) Methyl-l-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Neurology 2003;60:756ā761.
Pacia SV, Doyle WK, Broderick PA. Biogenic amines in the human neocortex in patients with neocortical and mesial temporal lobe epilepsy: identification with in situ microvoltammetry. Brain Res 2001;899-:106-111.
Watanabee K, Ashby CR Jr, Katsumoriand H,. Minabe Y. The effect of acute administration of various selective 5-HT receptor antagonists on focal hippocampal seizures in freely-moving rats. Eur J Pharmacol 2000; 398:239ā246.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Pacia, S.V., Broderick, P.A. (2005). Bioimaging L-Tryptophan in Human Hippocampus and Neocortex. In: Broderick, P.A., Rahni, D.N., Kolodny, E.H. (eds) Bioimaging in Neurodegeneration. Contemporary Neuroscience. Humana Press. https://doi.org/10.1007/978-1-59259-888-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-59259-888-5_13
Publisher Name: Humana Press
Print ISBN: 978-1-58829-391-6
Online ISBN: 978-1-59259-888-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)